PCM1 subgroups can be assigned within samples at the immune-clearance phase, which are known with the activation of HBeAg-specific T cell clones, inflammation [75], liver fibrosis, and inactive carriers, which constitute the largest group of CHB patients with normal ALT levels and minimal or no necroinflammation [76]. This evidence concerns the gene PCM1 and Hepatic fibrosis.